Young%20Girl%20Receiving%20Chemotherapy_edited.jpg

HEALTH VENTURE INCUBATOR

IMPACT HEALTH INCUBATOR

Accelerating Value and Impact in Healthcare

After two successful years in delivering the Australian Health Accelerator program, we are excited to announce kickoff of the Impact Health Incubator in 2021. EOI's for the 2021 program are now closed.

MIT GLOBAL ENTREPRENEURSHIP

We utilise MIT's world class disciplined entrepreneurship framework throughout the Health Accelerator Program

To learn more about the Impact Health Accelerator or Incubator programs submit an expression of interest via the button below

PORTFOLIO COMPANIES

We support companies accelerating improvement in healthcare outcomes, efficiency and access

We work with incredible businesses breaking down healthcare access barriers, eliminating healthcare inefficiencies, improving quality of care and quality of life.

ABOUT

Accelerating Value and Impact in Healthcare

ImpactXHealth is accelerating impact and value realization in healthcare through optimizing market access and facilitating strategic investments into companies involved in the development of breakthrough medical and healthcare technologies.

ImpactXHealth provides portfolio management, investment advisory, due diligence and governance services to venture capital funds, private investors, government and corporate finance organizations.

ImpactXHealth works directly with both private and public companies to support access to strategic capital, accelerate market access, reimbursement coverage and drive value growth.

SERVICES

VALUE AND IMPACT EVALUATION

Health Economics and Outcomes Modelling

INVESTMENT MANAGEMENT AND DUE DILIGENCE

Specialists in emerging medical technologies, diagnostics, digital health and precision therapeutics

REGULATORY, MARKET ACCESS AND GROWTH STRATEGY

Experts in navigating the intersection of regulatory strategy and reimbursement strategy to accelerate market access and value

TAMARA MILLS, MBA, MHECON, BSC, GAICD

Managing Director

Ms. Tamara Mills is Founder and Managing Director of ImpactXHealth, an organization supporting the growth and development of the Australasian health innovation ecosystem through both accelerating value realization and facilitating strategic investments into companies involved in the development of breakthrough medical and healthcare technologies. ImpactXHealth provides investment advisory, due diligence and investment governance services to venture capital funds, private investors and corporate finance organizations. ImpactXHealth also works directly with both private and publicly listed companies to support access to strategic capital and drive value growth.

Tamara has founded, funded and led a number of companies at the intersection of healthcare and the creative industries, including Glucotek, De Motu Cordis, merging design and science to disrupt current state of care, and has a track record in driving asset growth and value realisation. Tamara currently sits on the Investment Advisory Committee of Uniseed, one of Australia’s most successful early stage life-sciences venture capital funds advising on investment decisions in the emerging health technology space and actively manages the venture capital funds for Creative Enterprise Australia.

Tamara has extensive experience in the commercialization of innovative medical technologies across the United States, Japan, Brazil, Europe and Australia, having held executive level positions within Australia and internationally at both publicly listed and private companies.

Tamara has a strong track record in alternative asset portfolio management in having previously managed the pipeline of portfolio of assets (pharmaceutical and medical device products) for Jubilant life sciences in North America, leading investment due diligence, governance, licensing, mergers and acquisitions. Prior to returning to Australia, Tamara built and led the Cardiovascular Business for Jubilant Life Sciences, where she successfully led multiple complex pharmaceutical and medical device products from proof of concept through to regulatory approval and commercialization.

Tamara has held several board positions in the health technology sector, and she is active in the field of diagnostic and therapeutic technology development, and most recently held the position of Chair of the Health Policy, Regulatory and Reimbursement committee for the North American Radiopharmaceutical Industry organization CORAR in addition to holding a key leadership role for the Medical Imaging Technology Alliance.

Tamara holds a Master’s in Business Administration, Masters in Health Economics, a Degree in Applied Nuclear Physics and a qualification in New Ventures Leadership from the Massachusetts Institute of Technology. Tamara currently holds position as Co-Chair at Ausbiotech and is a Graduate of the Australian Institute of Company Directors.